miR-211 induction was confirmed in vivo by analyzing TRPM1 levels in tumor biopsies obtained from patients with metastatic melanoma who eventually progressed on treatment with BRAFi and/or MEKi. Here, TRPM1 is linked to metastatic melanoma.